Results 161 to 170 of about 314,852 (352)

An ancient DNA perspective on the Russian conquest of Yakutia. [PDF]

Nature
Crubézy É, Guarino-Vignon P, Seguin-Orlando A, Der Sarkissian C, Hanghøj K, Duchesne S, Gérard P, Thèves C, Alcouffe A, Romanova L, Nikolaeva D, Alekseeva L, Hochstrasser-Petit C, Zvénigorosky V, Keyser C, Ludes B, Petit M, Dabernat H, Géraut A, Jyrkov E, Sharaborin A, Kirianov N, Tsydenova N, Dambueva I, Bazarof B, Boland A, Deleuze JF, Bravina R, Alexeev A, Patin É, Stépanoff C, Quintana-Murci L, Orlando L.   +32 more
europepmc   +1 more source

The Conquest of Disease through Animal Experimentation . By J. P. Warbasse, M.D. Pp. xii + 176. New York, D. Appleton & Co. 1910.

, 1910
Steven J. Holmes
openalex   +2 more sources

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Successful Percutaneous Retrieval of a Trapping Balloon Protective Tube Embolized in the Coronary Artery. [PDF]

JACC Case Rep
Kobayashi H, Higami H, Matsuo H.
europepmc   +1 more source

TREND: Xignite. FactSet Corporate Fundamentals: 5 Year Annual Income Growth Rate | Stock Symbol: AAPL | Symbol Name: Apple Inc, 11/21/2011 - 11/11/2016. Data-Planet™ Statistical Datasets by Conquest Systems, Inc. Dataset-ID: 016-005-010

, 2016
Xignite
openalex   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Practical strategies for achieving system change in the US: lessons and insights from the CONQUEST quality improvement programme. [PDF]

Prim Health Care Res Dev
Evans A, VanWyk J, Kerr M, Couper A, Pace WD, Tarabichi Y, Pullen R, Pollack M, Drummond MB, Ohar J, Meldrum C, Han MK, Kaplan A, Winders T, Wisnivesky J, Make B, Federman A, Carter V, Lang K, Mapel D, Hanania NA, Stolz D, Martinez FJ, Price D.   +23 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Insight into the electronic, optical, and thermoelectric properties of novel ternary chalcohalides: next-generation energy applications. [PDF]

RSC Adv
Khan MS, Binzowaimil AM, Stampfl C, Fakhera F, Conquest OJ, Al-Hmoud M, Aziz SM.   +6 more
europepmc   +1 more source

Conquest of the Tropics

, 2011
Frederick Upham Adams
openalex   +2 more sources